-
Ariadne Solutions
-
Ariadne Solutions
-
Ariadne Solutions
-
Ariadne Solutions
-
Ariadne Solutions
AAPS News Magazine Feature
/ News and Events / 0 commentsThe July 2021 AAPS News Magazine featured an article on “Artificial Intelligence in Drug Discovery and Development – Challenges and Recommendations” authored by Stephanie Pasas-Farmer, PhD and Rashi Jain. This article discusses the challenges that the pharmaceutical industry is facing in adoption of AI despite witnessing its power and value.
-
Ariadne Solutions
“The Power of Story and Science” Podcast
/ Events, News and Events / 0 commentsStephanie Pasas-Farmer had a problem. Drawing upon the field of artificial intelligence, she had created a software tool to make her own job as a pharmaceutical researcher less tedious while improving the quality of her data. But once she formed a company to sell that tool to others, she encountered unexpected resistance. Potential users feared the software might replace their jobs. Or that the emphasis on quality implied there was something wrong with their work.
-
Ariadne Solutions
Ariadne Software, an Artificial Intelligence Software Developer, Moves to Lawrence, KS and Secures a Small Business Loan
/ News and Events / 0 commentsLAWRENCE, KS, March 8, 2021 ̶ On February 25, 2021, the Lawrence Chamber of Commerce officially welcomed Ariadne Software®, LLC to Lawrence, Kansas. Ariadne, a pharmaceutical software developer, employs advanced computational techniques and artificial intelligence to review and audit scientific data generated during drug discovery and development. The company, which moved from Philadelphia to Lawrence, has been growing and has added a job and an internship in the past four months in the Lawrence area. To add more resources, Ariadne leveraged the resources provided by the city and the Lawrence Chamber of Commerce to get a small business loan awarded from the Kansas Community Investment Fund through NetWork Kansas and Great Plains Development, Inc. on March 5, 2021.
-
Ariadne Solutions
AAPS E-Chalk Talk: Balance Study Design for Anti-Drug Antibody Cut Point Analysis
/ Events, News and Events / 0 commentsBalance design and its requirement in the successful establishment of an Anti-Drug Antibody (ADA) cut point is a hot button topic currently. Although it is stated directly in the FDA 2019 guidance that “balance study designs should be used for cut-point determination”, this requirement is not strictly followed within the industry. Many reasons are reported for this lack of adherence to this recommendation the most prevalent one being that this approach is more of a “nice to have” rather than a “must have” for appropriate setting of a cut point during validation. The goal for this e-Chalk Talk is to walk through a general overview of what a balance design is and why it is truly needed to successfully set a cut point for ADA determination.
-
Ariadne Solutions
Ariadne Software’s Ribbon Cutting Ceremony
/ Events, News and Events / 0 commentsJoin us via Facebook Live for a virtual ribbon cutting to celebrate with Ariadne Software, LLC on February 25 at 4:00pm!
-
Ariadne Solutions
Red Thread™ To Simplify Cut-Point Analysis for Immunogenicity/ADA Studies
/ News and Events / 0 commentsLAWRENCE, K.A., October 30, 2020 ̶ Ariadne Software continues its journey to simplify the most challenging areas of bioanalysis by announcing the launch of its new Red Thread™ module for Immunogenicity/Anti-drug Antibody (ADA) cut-point analysis for biologics. Ariadne Software uses the power of expert systems to simplify and automate the tedious, time-intensive and complicated process of analyzing cut-points for ADA studies.
